NKT Cells as an Ideal Anti-Tumor Immunotherapeutic

Por Fujii, Shin-ichiro, Shimizu, Kanako, Okamoto, Yoshitaka, Kunii, Naoki, Nakayama, Toshinori, Motohashi, Shinichiro, Taniguchi, Masaru
Publicado em 2013

Invariant NKT cells are resistant to circulating CD15(+) myeloid‐derived suppressor cells in patients with head and neck cancer

Por Horinaka, Atsushi, Sakurai, Daiju, Ihara, Fumie, Makita, Yuji, Kunii, Naoki, Motohashi, Shinichiro, Nakayama, Toshinori, Okamoto, Yoshitaka
Publicado no Cancer Sci (2016)

Enhanced Function of Redirected Human T Cells Expressing Linker for Activation of T Cells That Is Resistant to Ubiquitylation

Por Kunii, Naoki, Zhao, Yangbing, Jiang, Shuguang, Liu, Xiaojun, Scholler, John, Balagopalan, Lakshmi, Samelson, Lawrence E., Milone, Michael C., June, Carl H.
Publicado em 2013

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells

Por Kamata, Toshiko, Suzuki, Akane, Mise, Naoko, Ihara, Fumie, Takami, Mariko, Makita, Yuji, Horinaka, Atsushi, Harada, Kazuaki, Kunii, Naoki, Yoshida, Shigetoshi, Yoshino, Ichiro, Nakayama, Toshinori, Motohashi, Shinichiro
Publicado no Cancer Immunol Immunother (2016)